Rapid cardiovascular disease test M042-C

CRPmyoglobincTnI

There are several cardiac markers that can be used for acute myocardial infarction (AMI) diagnosis, such as CK-MB, Myoglobin, Troponin I, CRP, FABP and IMA. Amid the acute infarct, the timeline of elevated level of cardiac markers in blood is as follows: Myoglobin (1hr) → cTnI / cTnT (4hr) → CK-MB (4hr) → FABP (6hr) → CRP (14hr) → LD-1 (24hr). The Firstep Cardiac Marker Test is a sandwich immunochromatographic assay, it detects cardiac markers in blood qualitatively for preliminary screening. This test should not be used as the sole criteria for the diagnosis of acute myocardial infarction, in suspected case further confirmation shall be made by physician. Product Features • Short processing time • Easy operation and result interpretation • No instrument needed, results visible to the naked eye • Diverse testing items Scope of application Patients suspected of having Acute Myocardial Infarction. Creatine kinase-MB isozyme is a dimeric soluble protein in cardiac muscle. Following myocardial damage, CK-MB is rapidly released into the bloodstream within 4 to 6 hours after acute myocardial infarction (AMI). Therefore, it can be detected by CK-MB test which is a rapid chromatographic immunoassay for the detection of cardiac CK-MB. This test can be used together with other diagnostic methods (such as Troponin I and/or Myoglobin tests) to assess cardiac damage caused by AMI.